We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medcura’s injectable biopolymer LifeFoam significantly extended survival time in an animal study, researchers reported in the journal Surgery. Read More
Philips has agreed to pay more than $24 million to resolve False Claims Act allegations that it misled federal health care programs by paying kickbacks to durable medical equipment (DME) suppliers, said the Department of Justice (DOJ) in a statement. Read More
Alexandria, Va.-based Spok received a Form 483 after an April inspection by the FDA found incomplete corrective and preventive action (CAPA) procedures and design control lapses. Read More
A pilot project to help melanoma patients track and manage their symptoms and improve communication with their doctors is growing into a full-blown partnership between Kaiku Health and Novartis. Read More
The FDA has denied a request by Intarcia for a hearing on its New Drug Application (NDA) for the company’s investigational drug-device product ITCA 650 (exenatide) for treatment of type 2 diabetes. Read More
Patients with type 1 diabetes using Medtronic’s MiniMed 780G insulin pump system had reduced blood glucose levels and increased time spent in the target blood sugar range compared to patients given insulin injections, researchers reported in the journal The Lancet Diabetes & Endocrinology. Read More